<code id='88D81A6086'></code><style id='88D81A6086'></style>
    • <acronym id='88D81A6086'></acronym>
      <center id='88D81A6086'><center id='88D81A6086'><tfoot id='88D81A6086'></tfoot></center><abbr id='88D81A6086'><dir id='88D81A6086'><tfoot id='88D81A6086'></tfoot><noframes id='88D81A6086'>

    • <optgroup id='88D81A6086'><strike id='88D81A6086'><sup id='88D81A6086'></sup></strike><code id='88D81A6086'></code></optgroup>
        1. <b id='88D81A6086'><label id='88D81A6086'><select id='88D81A6086'><dt id='88D81A6086'><span id='88D81A6086'></span></dt></select></label></b><u id='88D81A6086'></u>
          <i id='88D81A6086'><strike id='88D81A6086'><tt id='88D81A6086'><pre id='88D81A6086'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:8
          Johnson & Johnson sign
          MARK RALSTON/AFP via Getty Images

          WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

          J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

          advertisement

          The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Vertex non
          Vertex non

          JOSEPHPREZIOSO/AFPviaGettyImagesLate-stagetrialresultsforapainmedicationdevelopedbyVertexPharmaceuti

          read more
          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more

          'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

          5:06RepublicanpresidentialcandidateFloridaGov.RonDeSantisspeaksduringafundraisingeventforU.S.Rep.Ash